Education and Training
Blood and Marrow Transplant Clinical Research Network
The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: fluconazole
- drug: voriconazole
- procedure: bone marrow transplant
- drug: thalidomide
- drug: dexamethasone
Eligibility
Criteria for entry into a study varies by protocol
Ages Eligible for Study
2 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Not Recruiting